Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis

Participants had clinically relevant active infections (such as sepsis, pneumonia, or abscess) or severe infections (resulting in hospitalization or requiring antibiotic treatment) in the 4 weeks before randomization;

Those with a history of high-risk tuberculosis infection, acquired tuberculosis infection, and chronic hepatitis;

Human immunodeficiency virus (HIV) infection;

Thymomas that have received thymectomy or planned thymectomy during RCP within 6 months before randomization, or require chemotherapy and/or radiotherapy at any time;